Number of the records: 1  

nivolumab

  1. Subject h.nivolumab
    Subject h.Nivolumab
    Entry termsBMS-936558
    MDX-1106
    ONO-4538
    Opdivo
    Scope note in EnglishA genetically engineered, fully humanized immunoglobulin G4 monoclonal antibody that binds to the PD-1 RECEPTOR, activating an immune response to tumor cells. It is used as monotherapy or in combination with IPILIMUMAB for the treatment of advanced malignant MELANOMA. It is also used in the treatment of advanced or recurring NON-SMALL CELL LUNG CANCER; RENAL CELL CARCINOMA; and HODGKIN'S LYMPHOMA.
    Links (28) - ARTICLES
    (2) - CiBaMed
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.